Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration
Clinical trial NCT03040362 · COMPLETED
Trial details
- NCT number
- NCT03040362
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2017-05-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.